Results of a new study presented at the 82nd Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS) offer new hope to stroke patients suffering from lost brain function, a condition thought to be irreversible until now. In the first North American trial of its kind, researchers conducted intraparenchymal transplantation of bone marrow-derived cell therapy in chronic stroke patients. Titledi A Novel Phase 1/2A Study of Intraparenchymal ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment